Literature DB >> 36094363

Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention.

Tsung-Ying Tsai1,2, Hsin-Bang Leu1,3,4,5, Pai-Feng Hsu1,3,4,5, Ya-Ling Yang1,5, Su-Chan Chen1,5, Shao-Sung Huang1,3,4, Wan Leong Chan1,4, Shing-Jong Lin1,4,5, Jaw-Wen Chen1,3,4,5, Ju-Pin Pan1,4, Min-Ji Charng1,4, Ying-Hwa Chen1,4, Tao-Cheng Wu1,4, Tse-Min Lu1,3,4, Po-Hsun Huang1,4, Hao-Min Cheng1,4,5, Chin-Chou Huang1,4, Shih-Hsien Sung1,4, Yenn-Jiang Lin1,4, Cheng-Hsueh Wu1,4.   

Abstract

Blood pressure variability (BPV) is independently associated with higher cardiovascular risks. However, whether BPV is associated with poor outcomes for coronary artery disease (CAD) patients after percutaneous coronary intervention (PCI) remained undetermined. We aimed to investigate the relationship between BPV and the outcomes of CAD patients undergoing PCI. Two thousand seven hundred and sixty-two CAD patients (1938 males, mean age 69.6 ± 12.9) who received PCI at Taipei Veterans General Hospital from 2006 to 2015 with multiple blood pressure measurements before and after the index PCI were enrolled. We calculated the standard deviation of systolic blood pressure, diastolic blood pressure, and pulse pressure as parameters of BPV. The primary endpoint was the composite of major adverse cardiovascular events [MACE comprising of cardiovascular death, nonfatal myocardial infarction (MI), and non-fatal stroke] and heart failure hospitalization (HHF). The key secondary endpoint was MACE. Both pre-PCI and post-PCI BPV were associated with CV events even after adjusting for co-morbidities and mean blood pressure. In Cox analysis, for every 1 mmHg increase in systolic BPV, the hazard ratio for the MACE + HHF, MACE, HHF, and cardiovascular death was 1.04 (95%CI: 1.03-1.05), 1.04 (95%CI: 1.02-1.05), 1.05 (95%CI: 1.04-1.06), and 1.06 (95%CI: 1.03-1.09), respectively. The association between BPV and cardiovascular risk is independent of blood pressure control status. The prognostic value of BPV was superior to mean blood pressure in both pre-PCI and post-PCI period. BPV is independently associated with cardiovascular events after PCI and has a better prognostic value than mean blood pressure suggesting the importance of maintaining stable blood pressure for CAD patients.
© 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.

Entities:  

Keywords:  blood pressure variability; coronary artery disease; outcome; percutaneous coronary intervention

Mesh:

Year:  2022        PMID: 36094363      PMCID: PMC9581098          DOI: 10.1111/jch.14565

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   2.885


  32 in total

1.  What is the optimal blood pressure and drug therapy for patients with coronary artery disease?

Authors:  Carl J Pepine
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

2.  Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease.

Authors:  Michiaki Nagai; Satoshi Hoshide; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Am Soc Hypertens       Date:  2011 May-Jun

3.  Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.

Authors:  Adam de Havenon; Nora F Fino; Brian Johnson; Ka-Ho Wong; Jennifer J Majersik; David Tirschwell; Natalia Rost
Journal:  Stroke       Date:  2019-09-20       Impact factor: 7.914

4.  Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

Authors:  Emmanuelle Vidal-Petiot; Ian Ford; Nicola Greenlaw; Roberto Ferrari; Kim M Fox; Jean-Claude Tardif; Michal Tendera; Luigi Tavazzi; Deepak L Bhatt; Philippe Gabriel Steg
Journal:  Lancet       Date:  2016-08-30       Impact factor: 79.321

5.  Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

Authors:  Franz H Messerli; Giuseppe Mancia; C Richard Conti; Ann C Hewkin; Stuart Kupfer; Annette Champion; Rainer Kolloch; Athanase Benetos; Carl J Pepine
Journal:  Ann Intern Med       Date:  2006-06-20       Impact factor: 25.391

6.  Survival in treated hypertension: follow up study after two decades.

Authors:  O K Andersson; T Almgren; B Persson; O Samuelsson; T Hedner; L Wilhelmsen
Journal:  BMJ       Date:  1998-07-18

7.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Peter S Sever; Neil R Poulter
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

8.  Survival with treated and well-controlled blood pressure: findings from a prospective cohort study.

Authors:  Debbie A Lawlor; Lois Kim; Richard Morris; Antoinette Amuzu; Peter Whincup; Shah Ebrahim
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

9.  How important is blood pressure variability?

Authors:  Enrico Agabiti Rosei; Giulia Chiarini; Damiano Rizzoni
Journal:  Eur Heart J Suppl       Date:  2020-04-06       Impact factor: 1.803

10.  Association between Preoperative Nutritional Status and Clinical Outcomes of Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Su-Chan Chen; Ya-Ling Yang; Cheng-Hsueh Wu; Shao-Sung Huang; Wan Leong Chan; Shing-Jong Lin; Chia-Yu Chou; Jaw-Wen Chen; Ju-Pin Pan; Min-Ji Charng; Ying-Hwa Chen; Tao-Cheng Wu; Tse-Min Lu; Pai-Feng Hsu; Po-Hsun Huang; Hao-Min Cheng; Chin-Chou Huang; Shih-Hsien Sung; Yenn-Jiang Lin; Hsin-Bang Leu
Journal:  Nutrients       Date:  2020-05-02       Impact factor: 5.717

View more
  1 in total

1.  Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention.

Authors:  Tsung-Ying Tsai; Hsin-Bang Leu; Pai-Feng Hsu; Ya-Ling Yang; Su-Chan Chen; Shao-Sung Huang; Wan Leong Chan; Shing-Jong Lin; Jaw-Wen Chen; Ju-Pin Pan; Min-Ji Charng; Ying-Hwa Chen; Tao-Cheng Wu; Tse-Min Lu; Po-Hsun Huang; Hao-Min Cheng; Chin-Chou Huang; Shih-Hsien Sung; Yenn-Jiang Lin; Cheng-Hsueh Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09-12       Impact factor: 2.885

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.